Generic Drug Market in Canada

Summary

Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. In 2008, generics accounted for more than 51% prescriptions and around 23% sales of the total pharmaceutical market. The Canadian generics market is benefitting from several factors such as patent expiry of several blockbuster drugs, lower costs, cost containment measures by the government and rapidly ageing population, according to "Generic Drug Market in Canada", a comprehensive market research report.

The report thoroughly evaluates factors that distinguish Canada from other generics markets both in positive and negative ways. A major factor that differentiates the Canadian generics market from the US and most European markets is comparatively higher prices of generics and lower price erosion. As this characteristic of the market allows manufacturers to fetch better margins from their drugs, many foreign players have shown keen interest to enter the Canadian generics market to make most of this lucrative characteristic.

At present, drugs to treat chronic diseases account for most of the pharmaceutical market, with cardiovascular drugs holding the top spot. However, strong growth is expected in other chronic segments, particularly in cancer and diabetes.

Although the Canadian generics market has huge growth potential, recent government regulations and various other challenges can significantly hamper the development of the market. However, low cost of generics and billion dollar drug patent expiries will enable the generics market to continue its double-digit growth in the next five years.

Table of Contents

1. Analyst View
2. Macroeconomic and Healthcare Factors
     2.1 Macroeconomic Indicators
     2.2 Population Profile
     2.3 Age Profile
     2.4 Healthcare Spending and Infrastructure
3. Pharmaceutical Market
     3.1 Market Size and Growth
            3.1.1 Prescriptions
            3.1.2 Sales
     3.2 By Therapeutic Category
     3.3 By Drug Category
     3.4 Healthcare Expenditure
     3.5 Top Selling Drugs
            3.5.1 Prescriptions
            3.5.2 Sales
4. Generics Market Attractions
     4.1 Favorable Political Environment
     4.2 Aging Population
     4.3 Patent Expiration
     4.4 High Returns for Pharmacists
     4.5 Huge Cost Savings
5. Generics Market
     5.1 Market Size and Growth
            5.1.1 Prescriptions
            5.1.2 Sales
     5.2 By Province/Territories
            5.2.1 Drug Consumption
            5.2.2 Prescriptions
            5.2.3 Sales
     5.3 Market Segmentation
            5.3.1 Retail Pharmacies
                      5.3.1.1 Sales
            5.3.2 Hospital Pharmacies
                      5.3.2.1 Sales
            5.3.3 Authorized and Independent Generics
            5.3.4 Distribution Channels
6. Generics Market - Opportunity Areas
     6.1 Cardiovascular Drugs
     6.2 Psytherapeutics
     6.3 Cholesterol Agents
     6.4 Antidiabetics
7. Forecast for Branded and Generic Drug to 2013
8. Key Players
     8.1 Pharmaceutical Market
            8.1.1 Prescriptions
            8.1.2 Sales
     8.2 Generics Market
            8.2.1 Prescriptions
            8.2.2 Sales
            8.2.3 Retail Pharmacies
            8.2.4 Hospital Pharmacies
9. General Approval Process
     9.1 Abbreviated New Drug Submission
     9.2 Notice of Allegation
10. Industry Roadblock
     10.1 Extension of Data Exclusivity
     10.2 Ever-greening of Drug Patents
     10.3 Authorized Generics

List of Figures:

Figure 2-1: Nominal GDP (Billion US$), 2002-2008
Figure 2-2: Consumer Price Index (%), 2002-2008
Figure 2-3: Forecast for Consumer Price Index (%), 2009-2013
Figure 2-4: Currency Exchange Rate (From CAD to US$), 2002-2008
Figure 2-5: Population (Million), 2002-2008
Figure 2-6: Forecast for Population (Million), 2009-2013
Figure 2-7: Life Expectancy (Years), 2002-2008
Figure 2-8: Forecast for Life Expectancy (Years), 2009-2013
Figure 2-9: Population Breakup by Age Group (%), 2002-2008
Figure 2-10: Forecast for Population Breakup by Age Group (%), 2009-2013
Figure 2-11: Per Head Healthcare Spending (US$), 2002-2008
Figure 2-12: Forecast for Per Head Healthcare Spending (US$), 2009-2013
Figure 2-13: Number of Doctors (per '000 Population), 2002-2008
Figure 2-14: Forecast for Number of Doctors (2009-2013)
Figure 2-15: Number of Hospital Beds (per '000 Population), 2002-2008
Figure 2-16: Forecast for Number of Hospital Beds (per '000 Population), 2009-2013
Figure 3-1: Prescriptions Dispensed in Pharmaceutical Market (Million), 2007 & 2008
Figure 3-2: Pharmaceutical Sales (Billion CAD), 2005-2008
Figure 3-3: Pharmaceutical Purchases by Retail and Hospital Pharmacies (Billion CAD), 2005-2008
Figure 3-4: Deaths by Various Causes (%), 2005 & 2008
Figure 3-5: Share of Generic and Branded Drug by Prescription (2008)
Figure 3-6: Share of Generic and Branded Drug by Sales (2008)
Figure 3-7: Drug Financing by Source (%), 2008
Figure 4-1: Population above 65 Years of Age (Million), 2002-2008
Figure 4-2: Average Cost of Branded and Generic Drug (CAD), 2002-2008
Figure 5-1: Prescriptions Dispensed in Branded Drug Market (Million), 2002-2008
Figure 5-2: Prescriptions Dispensed in Generic Drug Market (Million), 2002-2008
Figure 5-3: Share of Generic and Branded Drug by Prescription (2002-2008)
Figure 5-4: Generic Drug Sales (Billion CAD), 2002-2008
Figure 5-5: Branded Drug Sales (Billion CAD), 2002-2008
Figure 5-6: Share of Generic and Branded Drug by Sales (2002-2008)
Figure 5-7: Branded Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
Figure 5-8: Generic Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
Figure 5-9: Share of Generic and Branded Drug Sales through Retail Pharmacies (2005-2008)
Figure 5-10: Branded Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
Figure 5-11: Generic Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
Figure 5-12: Share of Generic and Branded Drug Sales through Hospital Pharmacies (2005-2008)
Figure 5-13: Share of Independent Generic and Authorized Generic Prescriptions (2002-2008)
Figure 5-14: Generic Drug Market by Retail and Hospital Sales (%), 2008
Figure 6-1: Cardiovascular Drug Market (Billion CAD), 2005-2008 & 2013
Figure 6-2: Psychotherapeutics Market (Billion CAD), 2005-2008 & 2013
Figure 6-3: Cholesterol Agents Market (Billion CAD), 2005-2008 & 2013
Figure 6-4: Number of Diabetes Patients in Age Group 20-79 Years ('000), 2003, 2008 & 2025
Figure 6-5: Diabetes Therapy Market (Million CAD), 2005-2008 & 2013
Figure 7-1: Forecast for Pharmaceutical Sales (Billion CAD), 2009-2013
Figure 7-2: Forecast for Generic Drug Sales (Billion CAD), 2009-2013
Figure 7-3: Forecast for Branded Drug Sales (Billion CAD), 2009-2013
Figure 7-4: Forecast for Share of Branded and Generic Drugs by Prescription (2009-2013)
Figure 7-5: Forecast for Share of Branded and Generic Drugs by Sales (2009-2013)
Figure 7-6: Forecast for Contribution of Branded and Generic Drug Sales in Growth of Pharmaceutical Market (%), 2009 to 2013
Figure 8-1: Relation between Brand Sales and Number of Generic Entrants

List of Tables:

Table 3-1: Top Ten Therapy Areas by Prescription ('000), 2008
Table 3-2: Top Ten Therapy Areas by Sales ('000 CAD), 2008
Table 3-3: Top Twenty Drugs in Pharmaceutical Market by Prescription (Million), 2008
Table 3-4: Top Ten Drugs in Pharmaceutical Market by Sales (Million CAD), 2007
Table 4-1: Generic and Branded Drug Returns for Pharmacists (CAD)
Table 5-1: Per Capita Drug Spending of Public and Private Sector by Region (CAD), 2008
Table 5-2: Generic Drug Prescriptions Dispensed by Region (%), 2002-2008
Table 5-3: Generic Drug Sales by Region (%), 2004 & 2006
Table 5-4: Number of Retail Pharmacies by Category (2002-2008)
Table 5-5: Top Ten Therapy Areas by Hospital Sales (Million CAD), 2008
Table 5-6: Pharmaceutical Sales by Distribution Channel (%), 2002-2006
Table 8-1: Top Pharmaceutical Companies by Retail Prescription (Million), 2006
Table 8-2: Ranking of Top Pharmaceutical Companies by Retail Prescription (2004-2006)
Table 8-3: Top Pharmaceutical Companies by Sales (Million CAD), 2008
Table 8-4: Ranking of Top Pharmaceutical Companies by Sales (2006-2008)
Table 8-5: Top Generic Drug Companies by Prescription (Million), 2007
Table 8-6: Ranking of Top Generic Drug Companies by Prescription (2005-2007)
Table 8-7: Top Generic Drug Companies by Sales (Million CAD), 2007
Table 8-8: Ranking of Top Generic Drug Companies by Sales (2005-2007)
Table 8-9: Ranking of Top Generic Companies by Retail Sales (2007)
Table 8-10: Ranking of Top Generic Companies by Hospital Sales (2006)

E-news Subscription

Register to receive email alerts of new market research reports and upcoming events in your industry

Subscribe Now!

Contact our customer services team

+86-10-58303339

+86-10-58303342

+86-10-58303470
(Global)

Research Category